Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Int J Nanomedicine ; 19: 5739-5761, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38882545

RESUMEN

Proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules that have the capability to induce specific protein degradation. While playing a revolutionary role in effectively degrading the protein of interest (POI), PROTACs encounter certain limitations that impede their clinical translation. These limitations encompass off-target effects, inadequate cell membrane permeability, and the hook effect. The advent of nanotechnology presents a promising avenue to surmount the challenges associated with conventional PROTACs. The utilization of nano-proteolysis targeting chimeras (nano-PROTACs) holds the potential to enhance specific tissue accumulation, augment membrane permeability, and enable controlled release. Consequently, this approach has the capacity to significantly enhance the controllable degradation of target proteins. Additionally, they enable a synergistic effect by combining with other therapeutic strategies. This review comprehensively summarizes the structural basis, advantages, and limitations of PROTACs. Furthermore, it highlights the latest advancements in nanosystems engineered for delivering PROTACs, as well as the development of nano-sized PROTACs employing nanocarriers as linkers. Moreover, it delves into the underlying principles of nanotechnology tailored specifically for PROTACs, alongside the current prospects of clinical research. In conclusion, the integration of nanotechnology into PROTACs harbors vast potential in enhancing the anti-tumor treatment response and expediting clinical translation.


Asunto(s)
Neoplasias , Proteolisis , Humanos , Neoplasias/tratamiento farmacológico , Proteolisis/efectos de los fármacos , Animales , Antineoplásicos/química , Antineoplásicos/farmacología , Antineoplásicos/administración & dosificación , Nanopartículas/química , Nanomedicina/métodos , Nanotecnología/métodos , Sistemas de Liberación de Medicamentos/métodos , Portadores de Fármacos/química
2.
Membranes (Basel) ; 13(8)2023 Jul 27.
Artículo en Inglés | MEDLINE | ID: mdl-37623757

RESUMEN

Connecting organic building blocks by covalent bonds to design porous crystalline networks has led to covalent organic frameworks (COFs), consequently transferring the flexibility of dynamic linkages from discrete architectures to extended structures. By virtue of the library of organic building blocks and the diversity of dynamic linkages and topologies, COFs have emerged as a novel field of organic materials that propose a platform for tailor-made complex structural design. Progress over the past two decades in the design, synthesis, and functional exploration of COFs in diverse applications successively established these frameworks in materials chemistry. The large-scale synthesis of COFs with uniform structures and properties is of profound importance for commercialization and industrial applications; however, this is in its infancy at present. An innovative designing and synthetic approaches have paved novel ways to address future hurdles. This review article highlights the fundamental of COFs, including designing principles, coupling reactions, topologies, structural diversity, synthetic strategies, characterization, growth mechanism, and activation aspects of COFs. Finally, the major challenges and future trends for large-scale COF fabrication are outlined.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA